PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportstransverse myelitis
MeSH D009188 - transverse myelitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D009187:Myelitis
0 Companies
0 Drugs
Success rate
D020278:Cns demyelinating autoimmune diseases
0 Companies
0 Drugs
Success rate
D020361:Nervous system paraneoplastic syndromes
1 Company
1 Drug
$
Success rate
D009188: 
Transverse myelitis
30 Companies
1 Drug
$
Success rate
D009471:Neuromyelitis optica
3 Companies
2 Drugs
$
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
0%
0/2
Phase 3
20%
1/5
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
Baclofen
Novartis
Baclofen
UCB
Baclofen
Impax Laboratories
Baclofen
1
2
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use